Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Results of Radiation Therapy for Superficial Esophageal Cancer using the Standard Radiotherapy Method Recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group
Attiki: International Institute of Anticancer Research
Erscheinungsjahr
2006
Quelle
MEDLINE
Beschreibungen/Notizen
Background: Superficial esophageal cancer (SEC) is defined as esophageal cancer limited to the submucosal layers, including
mucosal cancer and submucosal cancer, and is squamous cell carcinoma in most patients. In 2000, the Japanese Society of Therapeutic
Radiology and Oncology (JASTRO) Study Group for SEC published a consensus guideline of standard radiotherapy methods. In this
study, the interim treatment outcomes of SEC patients, who had received radiation therapy following the standard radiotherapy
methods, were investigated. Patients and Methods: From 2000 to 2003, a total of 141 SEC patients were treated in 24 institutions
in Japan. Results: The 1-, 2- and 3-year survival rates were 95%, 90% and 90%, respectively, for patients with mucosal cancer
and 90%, 81% and 70%, respectively, for patients with submucosal cancer. The overall survival was better in patients who had
undergone chemotherapy than in patients who had received radiation therapy alone, though the difference was not statistically
significant. The clinical target volume (CTV) did not influence overall survival and intracavitary irradiation did not influence
the local control rate in either patients with mucosal or submucosal cancer. Radiation-induced esophageal ulcer was not observed
in this series. Conclusion: The standard radiotherapy methods are safe and effective for treating SEC. However, the usefulness
of chemotherapy and intracavitary irradiation and the optimal setting of the CTV should be clarified by future randomized
trials.